Literature DB >> 3616136

Electrocardiographic changes in T. cruzi-infected rats after the ajmaline test.

R B Bestetti, E G Soares, V N Sales-Neto, R Corrêa de Araujo, J S Oliveira.   

Abstract

Fifty-eight chronically T. cruzi-infected rats and 26 control rats were submitted to the ajmaline test (1 mg/kg, i.v. during ECG monitoring) after obtaining the resting ECG. Abnormal ECG tracings were detected in the resting ECG of 26 (44%) infected rats. After ajmaline injection, a decrease in heart rate was observed in control but not in infected rats. P wave enlargement, lengthening of the QRS complex, and increase of the PR as well as the QaT intervals were detected in all animals. Ajmaline induced right axis deviation in 7% of the control rats and left axis deviation in 26% of the controls, as well as in 23% of the T. cruzi-infected rats with abnormal resting ECG. However, after ajmaline injection, 7 (21%) of the 32 infected rats having normal resting ECG presented the following ECG changes not observed in control animals: indeterminate axis (15%), marked increase in PR interval and bizarre QRS complex (3%), and marked decrease in heart rate plus a significant increase in PR interval. These data show that ajmaline induces important ECG changes not only in controls, but also in T. cruzi-infected rats. Furthermore, since severe ECG changes occurred only in T. cruzi-infected rats having normal resting ECG, the ajmaline test can be used to unmask cardiac lesions in experimental chronic Chagas' disease.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3616136     DOI: 10.1007/bf01852082

Source DB:  PubMed          Journal:  Res Exp Med (Berl)        ISSN: 0300-9130


  1 in total

1.  The ajmaline test as a method to disclose latent experimental Chagas' heart disease.

Authors:  R B Bestetti; E G Soares; V N Sales-Neto; J S Oliveira
Journal:  Cardiovasc Drugs Ther       Date:  1989-04       Impact factor: 3.727

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.